You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Aerosol Sampling and Microfluidic Analysis of Reactive Oxygen Species
SBC: ILLIONIX, LLC Topic: 113DESCRIPTIONprovided by applicantCardiovascular diseases and Asthma affects betweenandmillion people in the United States includingmillion childrenduring the pastyearsits incidence worldwide has doubledAsthma is responsible formillion person days of restricted activity anddeaths per yearamounting to $billion in direct heath related coststhere is uncertainty about the specific factors that are contr ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of user-friendly fluorescence based assays for marine toxins
SBC: SEATOX RESEARCH INC Topic: 113ABSTRACTHarmful algal bloomsHABsare becoming frequent occurrences off the coasts of the United Stateswith specific instances in the coastal waters of the west coastthe Gulf of Mexicoand the Pacific OceanHistoricallyHABs have been associated with fish kills and marine mammal mortalitieshowevertheir effects on human health and economic loss due to HAB contamination of seafood are becoming more preva ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Web-Based Alcohol Misuse Prevention Intervention for the Elderly
SBC: ISA ASSOCIATES INC Topic: NIAAADESCRIPTIONprovided by applicantRecent data indicate that a substantial proportion of adultsyears of age and older are engaging in unsafeat risk drinkingeither based on the amount of alcohol they drink or alcohol use combined with other comorbidities or medicationsSeveral brief interventions to address the problem of excessive drinking in the elderlydesigned mainly for in person deliverymost in pr ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Phase 2 clinical trial of topical uracil for the prevention of capecitabine induced hand-foot syndrome
SBC: NANOMETICS LLC Topic: 102Problem to be SolvedCapecitabine is a widely prescribed and orally available prodrug of the chemotherapeutic agentfluorouracilFUThe principle dose schedule limiting toxicity associated with its use is Hand Foot syndromeHFSand occurs inof patients receiving capecitabineHFS manifests in the hands and feet of patientsand rapidly progresses to painful peelingblisteringand bleeding that commonly requir ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Regulatory Validation of Standardized Clinical Laboratory Immunohistochemistry Controls
SBC: BOSTON CELL STANDARDS INC. Topic: 102The broadlongterm goal of this project is consistentstandardized diagnostic testing of surgicalspecimens by immunohistochemistryIHCThe methods to achieve this goal are well understood in thefield of clinical laboratory testingstandardization of reagents and protocolsautomation toreduce human errorsandthe use of standardized controls to provide test performance feedbackOver the last two decadesthe ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood
SBC: BIOFLUIDICA, INC. Topic: 102AbstractAcute myeloid leukemiaAMLis the most common adult leukemia withnew cases expected inin the US and ayear survival rate of onlyThe primary cause of death for AML is due to disease relapseThe consequences of relapse are significant with it not atypical to see a relapse rate ofof which onlysurvive afteryearsIf clinicians could easily identify a patient s minimum residual diseaseMRDbefore the t ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Semantic Data Lake for Biomedical Research
SBC: INFOTECH SOFT, INC. Topic: 100Capitalizing on the transformative opportunities afforded by the extremely large and ever growing volumevelocityand variety of biomedical data being continuously produced is a major challengeThe development and increasingly widespread adoption of several new technologiesincluding next generation genetic sequencingelectronic health records and clinical trials systemsand research data warehouses mea ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
SBC: Curadel, LLC Topic: 102PROJECT SUMMARY ABSTRACTImage guided surgery using invisible near infraredNIRlight is in the midst of a renaissanceMultiple commercial imaging systemsincluding Curadel s state of the art FLAREsystemare available for preclinicalveterinaryand human surgeryHoweverthe ultimate success of the field will depend on innovative NIR fluorophores that solve important clinical problemsCuradel has invented a n ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of novel research tools and a database for mapping human mitochondrial tRNA modifications by mass spectrometry
SBC: Ribonova Inc. Topic: R42Summary In this fast track Phase I II STTR project a novel mass spectrometry method and a matched reagent kit will be developed for mapping modified nucleotides in human mitochondrial transfer RNA mt tRNA including the most abundant modification pseudouridine which hitherto has proved to be a technical challenge because it is an isomer of uridine These new research tools will be harnessed t ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer- [F-18]FDG
SBC: TRACE-ABILITY INC Topic: 102Project SummaryPositron Emission TomographyPETis regarded as a standard of care in the management of multiple types of cancerAvailability of this procedure relies on a steady supply of a radioactive contrast agentFFluorodeoxy d glucoseFDGDue to the inherent short half lifeminmultiple batches of FDG are typically produced at multiple sites on daily basisQuality ControlQCof FDG remains the most labo ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health